New FDA Approved Device for Treating Potentially Deadly Aneurysms Offered at Sentara Norfolk General Hospital
Sentara.com
You have saved None as your preferred region Undo or Change Region
HR
Hampton Roads
Login for:
Search:
Go Search
Home News News Archives 2006 Archive

New FDA Approved Device for Treating Potentially Deadly Aneurysms Offered at Sentara Norfolk General Hospital 

Skip navigation links
Sentara News Home
Online Newsroom
News Archives
Sentara in the News
Sentara Today

Norfolk, Va. - February 27, 2006 - Every year in the United States, an estimated 15,000 people die because of ruptured aortic aneurysms. But a new minimally invasive life saving procedure for the treatment of thoracic aortic aneurysms (TAA) is now available at Sentara Norfolk General Hospital.

This technologically advanced devicethe GORE TAG Thoracic Endoprosthesisis the first and only endovascular device approved by the FDA for treating TAAs. Prior to the approval of the GORE TAG device, patients were limited to traditional open-chest surgical repair, a procedure many patients with complex pre-existing conditions could not endure. This minimally invasive procedure represents a safer alternative to open-chest surgery. Based on clinical trials comparing the device to open surgical repair, the manufacturer, W.L.Gore & Associates, reports that the device offers patients the opportunity for fewer complications, less surgical blood loss, shortened hospital stays and a much faster return to normal activities.

Vascular surgeon, Marc H. Glickman, M.D., medical director for vascular services for Sentara Southside and Peninsula, and one of the vascular surgeons using the new device at Sentara Norfolk General Hospital said, This new procedure does offer a safer alternative to appropriate patients with thoracic aortic aneurysm than open heart surgery. Any time that we are able to correct a problem with a minimally invasive procedure, patients can expect shorter recovery periods and hospital stays.

Glickman, who is board certified in vascular surgery, explained that the thoracic endoprosthesis uses a synthetic graft to seal off an aneurysm inside a damaged aorta by creating a new path for blood flow. The stent is delivered into the site of the aneurysm through the use of guide wires, x-rays and an endovascular device that is inserted through small incisions in the leg.

TAAs are generally caused by hardening of the arteries (arteriosclerosis), high blood pressure, a family history of TAA or trauma. Often, people experience no symptoms until the aneurysm begins to leak or increases in size.

Sentara Norfolk General Hospital is a 569 bed tertiary care facility, home to the regions only Level I Trauma Center, burn unit, Nightingale Helicopter Ambulance, the regions only organ transplant program and the regions only dedicated heart hospitalSentara Heart Hospital. In 2005, Sentara Norfolk General Hospital was the first vascular center in the nation to earn the Gold Seal of Approval from the Joint Commission on Accreditation of Healthcare Organizations. Sentara Norfolk General Hospital cardiac and surgery programs also ranked among the nations top 50 programs in the 2005 survey in U.S. News & World Report.

Sentara Healthcare is a premier not-for-profit health care provider in southeastern Virginia and northeastern North Carolina. 
 
 

(14/2006)


Contact Us
Get Social with Sentara Sentara on Facebook Sentara on Twitter Sentara on Flickr Sentara on FourSquare Sentara Today Blog Sentara on YouTube
Your community, not-for-profit health partner.
Copyright © 2014 Sentara Healthcare.
Contact Us   About Sentara Healthcare   Privacy Policy   User Agreement   Mobile Site